SCHEMBL7544860

SCHEMBL7544860

COC(=O)Cc1cc(C(C)=O)ccc1OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.52
SMPD1 P17405 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
MRGPRX4 Q96LA9 1/20 0.50
NPC1 O15118 1/20 0.50
HPGD P15428 1/20 0.50
RAB9A P51151 1/20 0.50
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
MTNR1B P49286 2/20 0.48
MTNR1A P48039 1/20 0.48
ALDH1A1 P00352 2/20 0.47
LMNA P02545 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46
BRD4 O60885 2/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11179076 0.85 MAOB (0.56) MAOBSMPD1HDAC1HDAC8HDAC6
SCHEMBL10664626 0.84 MAOB (0.57) MAOBSMPD1HDAC1HDAC8HDAC6
SCHEMBL27540681 0.84 MRGPRX4 (0.54) MAOBSMN1; SMN2MRGPRX4NPC1HPGD
SCHEMBL15820919 0.83 CCR5 (0.60) SMN1; SMN2RAB9AALDH1A1LMNA
SCHEMBL21483708 0.83 MAOB (0.56) MAOBSMPD1HDAC1HDAC8HDAC6
SCHEMBL31757763 0.82 L3MBTL1 (0.56) HPGDKDM4EMEN1KMT2AMTNR1B
SCHEMBL2988197 0.82 L3MBTL1 (0.56) HPGDKDM4EMEN1KMT2AMTNR1B
SCHEMBL15338464 0.82 MAOB (0.55) MAOBSMPD1HDAC1HDAC8HDAC6
SCHEMBL21483714 0.82 ALDH1A1 (0.55) MAOBSMPD1HDAC1HDAC8HDAC6
SCHEMBL4034898 0.81 MTNR1A (0.54) SMPD1HDAC1HDAC8HDAC6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1100032-C 3,4-disubstituted phenylethanolaminotetra lincarboxamide derivatives KISSEI PHARMACEUTICAL (JP) 2003-01-29 CN disclosed
EP-0882704-B1 3,4-DISUBSTITUTED PHENYLETHANOLAMINOTETRALINCARBOXAMIDE DERIVATIVES KISSEI PHARMACEUTICAL (JP) 2002-10-09 EP disclosed
EP-0894787-B1 3,4-DISUBSTITUTED PHENYLETHANOLAMINOTETRALINCARBOXYLATE DERIVATIVES KISSEI PHARMACEUTICAL (JP) 2002-06-12 EP disclosed
US-6136852-A 3,4-disubstituted phenylethanolaminotetralincarboxylic acid derivatives KISSEI PHARMACEUTICAL CO., LTD. (JP) 2000-10-24 US disclosed
US-6133266-A 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives KISSEI PHARMACEUTICAL CO., LTD. (JP) 2000-10-17 US disclosed
CN-1216526-A 3,4-disubstituted phenylethanolaminotetra lincarboxamide derivatives KISSEI PHARMACEUTICAL (JP) 1999-05-12 CN disclosed
EP-0894787-A1 3,4-DISUBSTITUTED PHENYLETHANOLAMINOTETRALINCARBOXYLATE DERIVATIVES KISSEI PHARMACEUTICAL CO., LTD. (JP) 1999-02-03 EP disclosed
EP-0882704-A1 3,4-DISUBSTITUTED PHENYLETHANOLAMINOTETRALINCARBOXAMIDE DERIVATIVES KISSEI PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed